Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Necrosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02334748
What this trial is testing

Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis or Hereditary Periodic Fevers Who Participated in the CACZ885G2301E1, CACZ885G2306 or CACZ885N2301 Studies

Who this might be right for
Systemic Juvenile Idiopathic ArthritisHereditary Periodic Fevers
Novartis Pharmaceuticals 31
Post-approval studies (Phase 4)Study completedNCT02492217
What this trial is testing

Biomarkers Identification of Anti-tumor Necrosis Factor (TNF) α Agent's Efficacy in Ankylosing Spondylitis Patients

Who this might be right for
Ankylosing Spondylitis
Universidade Nova de Lisboa 69
Early research (Phase 1)Study completedNCT00707343
What this trial is testing

[F-18] Fluorothymidine (FLT) Imaging on Patients With Primary Brain Tumors

Who this might be right for
CancerBrain Tumors
University of Utah 15
Not applicableStudy completedNCT07237906
What this trial is testing

Neutropenia With TNF-α Inhibitors

Who this might be right for
NeutropeniaTNF-alpha Inhibitors
Burak Ugur Cetin 122
Large-scale testing (Phase 3)UnknownNCT00012506
What this trial is testing

The Safety and Efficacy of a Tumor Necrosis Factor Receptor Fusion Protein on Uveitis Associated With Juvenile Rheumatoid Arthritis

Who this might be right for
UveitisArthritis, Juvenile Rheumatoid
National Eye Institute (NEI)
Early research (Phase 1)Study completedNCT05909852
What this trial is testing

A Study Comparing the Pharmacokinetics (PK) of ABP 501 40 mg/0.4 mL (ABP 501-HCF) and ABP 501 40 mg/0.8 ml (ABP 501-LCF) in Healthy Adult Participants

Who this might be right for
Adalimumab
Amgen 372
Not applicableStudy completedNCT02759796
What this trial is testing

Fluorescence Angiography in the Assessment of DIEP Flap Perfusion

Who this might be right for
Breast CancerVascularizationFat Necrosis
Instituto de Investigación Hospital Universitario La Paz 60
Large-scale testing (Phase 3)Study completedNCT00000479
What this trial is testing

Women's Health Study (WHS): A Randomized Trial of Low-dose Aspirin and Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer

Who this might be right for
Cardiovascular DiseasesCerebrovascular DisordersCoronary Disease+4 more
Brigham and Women's Hospital 39,876
Large-scale testing (Phase 3)Study completedNCT02136069
What this trial is testing

A Study Comparing the Efficacy and Safety of Etrolizumab to Infliximab in Participants With Moderate to Severe Ulcerative Colitis Who Are Naïve to Tumor Necrosis Factor (TNF) Inhibitors

Who this might be right for
Ulcerative Colitis
Hoffmann-La Roche 397
Early research (Phase 1)Study completedNCT02145130
What this trial is testing

Phase I Study for Autologous Dermal Substitutes and Dermo-epidermal Skin Substitutes for Treatment of Skin Defects

Who this might be right for
Burn InjurySoft Tissue InjurySkin Necrosis+3 more
University of Zurich 12
Testing effectiveness (Phase 2)Study completedNCT00001955
What this trial is testing

Study of Etanercept and Celecoxib to Treat Temporomandibular Disorders (Painful Joint Conditions)

Who this might be right for
Temporomandibular Joint Disorder
National Institute of Dental and Craniofacial Research (NIDCR) 150
Early research (Phase 1)WithdrawnNCT04756505
What this trial is testing

Immunotherapy (NHS-IL12 & Bintrafusp Alfa) and Radiation Therapy for the Treatment of Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer, the REINA Trial

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Hormone Receptor Positive Breast AdenocarcinomaMetastatic Breast Carcinoma+2 more
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00537667
What this trial is testing

The SPECTRA Study

Who this might be right for
Rheumatoid Arthritis
Amgen 22
Not applicableStudy completedNCT02806934
What this trial is testing

TNF Polymorphism and Implantation Rate

Who this might be right for
Infertility
Centre Hospitalier Universitaire de Nice 120
Post-approval studies (Phase 4)Study completedNCT03649061
What this trial is testing

COBRA-Slim With or Without Fast Access to TNF Blockade for Remission Induction in Early RA

Who this might be right for
Arthritis, Rheumatoid
P. Verschueren 276
Not applicableUnknownNCT01104324
What this trial is testing

Osteonecrosis in Children With Acute Lymphoblastic Leukemia

Who this might be right for
OsteonecrosisAcute Lymphoblastic Leukemia
Halton, Jacqueline, M.D. 130
Not applicableLooking for participantsNCT06538870
What this trial is testing

Dental Implant Healing With TNF-Alpha Inhibitors

Who this might be right for
EdentulismDental ImplantsTNF-alpha Inhibitors
University of Pennsylvania 30
Not applicableStudy completedNCT04571697
What this trial is testing

Comparing Rates of Dementia and Alzheimer's Disease in Participants Initiating Methotrexate Versus Those Initiating Anti-tumor Necrosis Factor (TNF)-Alpha Therapy

Who this might be right for
DementiaAlzheimer Disease
Janssen Research & Development, LLC 34,647
Not applicableUnknownNCT04611308
What this trial is testing

The Role of C1q Tumor Necrosis Factor-related Protein 6 in Breast Cancer

Who this might be right for
Breast Cancer
Assiut University 102
Testing effectiveness (Phase 2)Active Not RecruitingNCT05271318
What this trial is testing

Oncolytic Adenovirus Coding for TNFa and IL2 (TILT-123) With Pembrolizumab or Pembrolizumab (Phase 1a) and Pegylated Liposomal Doxorubicin (Phase 1b) as Treatment for Ovarian Cancer.

Who this might be right for
Platinum-refractory Ovarian CarcinomaPlatinum-resistant Ovarian CancerPlatinum-Resistant Fallopian Tube Carcinoma+6 more
TILT Biotherapeutics Ltd. 29
Next Page